Pelabresib Constellation Pharmaceuticals Inhibitor 0610 (CPI-0610) is an investigational oral BET inhibitor that targets transcriptional regulators involved in myelofibrosis (1). It modulates megakaryocyte differentiation, proliferation, and reduces proinflammatory cytokine expression via the Nuclear Factor kappa-light-chain (NF-κB) pathway (1). BE
11 Reached
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Pancytopenia, a rare presentation of hyperthyroidism
830 Reached2 Comments
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Safe Ramadan Practices during COVID-19 - WHO Guidance
4873 Reached8 Comments3 Likes